期刊
CELL STEM CELL
卷 15, 期 5, 页码 537-538出版社
CELL PRESS
DOI: 10.1016/j.stem.2014.10.008
关键词
-
资金
- Fight for Sight [1351/52] Funding Source: researchfish
- Great Ormond Street Hospital Childrens Charity [V1257] Funding Source: researchfish
- Medical Research Council [G0901550] Funding Source: researchfish
- Rosetrees Trust [M257] Funding Source: researchfish
- MRC [G0901550] Funding Source: UKRI
- Medical Research Council [G0901550] Funding Source: Medline
Many untreatable blinding diseases involve degeneration of retinal pigmented epithelial (RPE) cells, which has prompted exploration of the therapeutic potential of human-pluripotent-stem-cell-derived RPE. The first safety trials reported in The Lancet of embryonic-stem-cell-derived RPE cell transplants indicate no serious adverse outcomes and encourage further investigation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
